US Sees 'Very Similar' Issues In J&J, AstraZeneca Vaccines
The federal government's recommended pause of Johnson & Johnson coronavirus vaccinations involves safety issues that have been called exceedingly rare, but unmistakably comparable to risks that U.K. and European Union regulators...To view the full article, register now.
Already a subscriber? Click here to view full article